Compare RLMD & HBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RLMD | HBCP |
|---|---|---|
| Founded | 2004 | 1908 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 461.9M | 546.5M |
| IPO Year | 2012 | 2008 |
| Metric | RLMD | HBCP |
|---|---|---|
| Price | $4.07 | $68.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $12.40 | ★ $65.50 |
| AVG Volume (30 Days) | ★ 1.1M | 53.8K |
| Earning Date | 05-08-2026 | 04-20-2026 |
| Dividend Yield | N/A | ★ 1.98% |
| EPS Growth | ★ 45.28 | 29.01 |
| EPS | N/A | ★ 2.93 |
| Revenue | ★ $13,070.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.97 |
| P/E Ratio | ★ N/A | $23.41 |
| Revenue Growth | ★ 154.83 | N/A |
| 52 Week Low | $1.47 | $50.54 |
| 52 Week High | $8.00 | $74.50 |
| Indicator | RLMD | HBCP |
|---|---|---|
| Relative Strength Index (RSI) | 35.21 | 42.63 |
| Support Level | $3.99 | $66.97 |
| Resistance Level | $4.51 | $68.65 |
| Average True Range (ATR) | 0.21 | 1.31 |
| MACD | 0.02 | -0.08 |
| Stochastic Oscillator | 12.31 | 39.83 |
Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.
Home Bancorp Inc is engaged in attracting deposits from the public and using those funds to invest in loans and securities.It is holding company for Home Bank, N.A. The principal sources of funds are customer deposits, repayments of loans, repayments of investments, and funds borrowed from outside sources such as the Federal Home Loan Bank of Dallas. These funds are used for the origination of loans, including one-to-four-family first mortgage loans, home equity loans, and lines, commercial real estate loans, construction and land loans, multi-family residential loans, commercial and industrial loans, and consumer loans.